Intravitreal ranibizumab, with or without filter?
Javier A
JA
Montero
Jose M
JM
Ruiz-Moreno
Eugenia
E
Sanchis-Merino
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D004340:Drug Contamination / Q000517:prevention & control*; D004349:Drug Packaging; D006801:Humans; D058449:Intravitreal Injections; D020315:Latex Hypersensitivity / Q000209:etiology*; D008851:Micropore Filters; D000069579:Ranibizumab; D012408:Rubber / Q000009:adverse effects*; D013594:Syringes; D057135:Wet Macular Degeneration / Q000188:drug therapy
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D012408:Rubber; D000069579:Ranibizumab